Abstract
For the year 2014, more than 17,000 published references can be found in Pubmed when entering the search term “cardiac surgery”. The last year has been characterized by a vivid discussion in the fields where classic cardiac surgery and modern interventional techniques overlap. Specifically, there have been important contributions in the field of coronary revascularization with either percutaneous coronary intervention or bypass surgery as well as in the fields of interventional valve therapy. Here, the US core valve trial with the first demonstration of a survival advantage at 1 year with transcatheter valves compared to surgical aortic valve replacement or the 5-year outcome of the SYNTAX trial with significant advantages for bypass surgery has been the landmark. However, in addition to these most visible publications, there have been several highly relevant and interesting contributions. This review article will summarize the most pertinent publications in the fields of coronary revascularization, surgical treatment of valve disease, heart failure (i.e., transplantation and ventricular assist devices) and aortic surgery. This condensed summary will provide the reader with “solid ground” for up-to-date decision-making in cardiac surgery.
Similar content being viewed by others
References
Sipahi I, Akay MH, Dagdelen S, Blitz A, Alhan C (2014) Coronary artery bypass grafting vs percutaneous coronary intervention and long-term mortality and morbidity in multivessel disease: meta-analysis of randomized clinical trials of the arterial grafting and stenting era. JAMA Int Med 174(2):223–230. doi:10.1001/jamainternmed.2013.12844
Head SJ, Davierwala PM, Serruys PW, Redwood SR, Colombo A, Mack MJ, Morice MC, Holmes DR Jr, Feldman TE, Stahle E, Underwood P, Dawkins KD, Kappetein AP, Mohr FW (2014) Coronary artery bypass grafting versus percutaneous coronary intervention for patients with three-vessel disease: final 5 year follow-up of the SYNTAX trial. Eur Heart J 35(40):2821–2830. doi:10.1093/eurheartj/ehu213
Panza JA, Velazquez EJ, She L, Smith PK, Nicolau JC, Favaloro RR, Gradinac S, Chrzanowski L, Prabhakaran D, Howlett JG, Jasinski M, Hill JA, Szwed H, Larbalestier R, Desvigne-Nickens P, Jones RH, Lee KL, Rouleau JL (2014) Extent of coronary and myocardial disease and benefit from surgical revascularization in LV dysfunction. J Am Coll Cardiol 64(6):553–561. doi:10.1016/j.jacc.2014.04.064
Dangas GD, Farkouh ME, Sleeper LA, Yang M, Schoos MM, Macaya C, Abizaid A, Buller CE, Devlin G, Rodriguez AE, Lansky AJ, Siami FS, Domanski M, Fuster V, Investigators F (2014) Long-term outcome of PCI versus CABG in insulin and non-insulin-treated diabetic patients: results from the FREEDOM trial. J Am Coll Cardiol 64(12):1189–1197. doi:10.1016/j.jacc.2014.06.1182
Kumada Y, Ishii H, Aoyama T, Kamoi D, Kawamura Y, Sakakibara T, Nogaki H, Takahashi H, Murohara T (2014) Long-term clinical outcome after surgical or percutaneous coronary revascularization in hemodialysis patients. Circ J 78(4):986–992
Naganuma T, Chieffo A, Meliga E, Capodanno D, Park SJ, Onuma Y, Valgimigli M, Jegere S, Makkar RR, Palacios IF, Costopoulos C, Kim YH, Buszman PP, Chakravarty T, Sheiban I, Mehran R, Naber C, Margey R, Agnihotri A, Marra S, Capranzano P, Leon MB, Moses JW, Fajadet J, Lefevre T, Morice MC, Erglis A, Tamburino C, Alfieri O, Serruys PW, Colombo A (2014) Long-term clinical outcomes after percutaneous coronary intervention versus coronary artery bypass grafting for ostial/midshaft lesions in unprotected left main coronary artery from the DELTA registry: a multicenter registry evaluating percutaneous coronary intervention versus coronary artery bypass grafting for left main treatment. JACC Cardiovasc Interventions 7(4):354–361. doi:10.1016/j.jcin.2013.11.014
Blazek S, Rossbach C, Borger MA, Fuernau G, Desch S, Eitel I, Stiermaier T, Lurz P, Holzhey D, Schuler G, Mohr FW, Thiele H (2014) Comparison of sirolimus-eluting stenting with minimally invasive bypass surgery for stenosis of the left anterior descending coronary artery: 7 year follow-up of a randomized trial. JACC Cardiovasc Interventions. doi:10.1016/j.jcin.2014.08.006
Deo SV, Sharma V, Shah IK, Erwin PJ, Joyce LD, Park SJ (2014) Minimally invasive direct coronary artery bypass graft surgery or percutaneous coronary intervention for proximal left anterior descending artery stenosis: a meta-analysis. Ann Thorac Surg 97(6):2056–2065. doi:10.1016/j.athoracsur.2014.01.086
Yi G, Shine B, Rehman SM, Altman DG, Taggart DP (2014) Effect of bilateral internal mammary artery grafts on long-term survival: a meta-analysis approach. Circulation 130(7):539–545. doi:10.1161/CIRCULATIONAHA.113.004255
Hoffman DM, Dimitrova KR, Lucido DJ, Dincheva GR, Geller CM, Balaram SK, Ko W, Swistel DG, Tranbaugh RF (2014) Optimal conduit for diabetic patients: propensity analysis of radial and right internal thoracic arteries. Ann Thorac Surg 98(1):30–36. doi:10.1016/j.athoracsur.2014.03.044 (discussion 36–37)
Moss E, Puskas JD, Thourani VH, Kilgo P, Chen EP, Leshnower BG, Lattouf OM, Guyton RA, Glas KE, Halkos ME (2015) Avoiding aortic clamping during coronary artery bypass grafting reduces postoperative stroke. J Thorac Cardiovasc Surg 149(1):175–180. doi:10.1016/j.jtcvs.2014.09.011
Cavallaro P, Itagaki S, Seigerman M, Chikwe J (2014) Operative mortality and stroke after on-pump vs off-pump surgery in high-risk patients: an analysis of 83,914 coronary bypass operations. Eur J Cardiothorac Surg 45(1):159–164. doi:10.1093/ejcts/ezt221
Kim JB, Yun SC, Lim JW, Hwang SK, Jung SH, Song H, Chung CH, Lee JW, Choo SJ (2014) Long-term survival following coronary artery bypass grafting: off-pump versus on-pump strategies. J Am Coll Cardiol 63(21):2280–2288. doi:10.1016/j.jacc.2014.02.584
Ruel M, Shariff MA, Lapierre H, Goyal N, Dennie C, Sadel SM, Sohmer B, McGinn JT Jr (2014) Results of the minimally invasive coronary artery bypass grafting angiographic patency study. J Thorac Cardiovasc Surg 147(1):203–208. doi:10.1016/j.jtcvs.2013.09.016
Authors/Task Force m, Windecker S, Kolh P, Alfonso F, Collet JP, Cremer J, Falk V, Filippatos G, Hamm C, Head SJ, Juni P, Kappetein AP, Kastrati A, Knuuti J, Landmesser U, Laufer G, Richter DJ, Schauerte P, Sousa Uva M, Stefanini GG, Torracca L, Valgimigli M, Wijns W, Witkowski A, Authors/Task Force m (2014) ESC/EACTS Guidelines on myocardial revascularization: the Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur Heart J 35(37):2541–2619 10.1093/eurheartj/ehu278
Windecker S, Stortecky S, Stefanini GG, da Costa BR, Rutjes AW, Di Nisio M, Silletta MG, Maione A, Alfonso F, Clemmensen PM, Collet JP, Cremer J, Falk V, Filippatos G, Hamm C, Head S, Kappetein AP, Kastrati A, Knuuti J, Landmesser U, Laufer G, Neumann FJ, Richter D, Schauerte P, Sousa Uva M, Taggart DP, Torracca L, Valgimigli M, Wijns W, Witkowski A, Kolh P, Juni P (2014) Revascularisation versus medical treatment in patients with stable coronary artery disease: network meta-analysis. BMJ 348:g3859. doi:10.1136/bmj.g3859
de Waha A, Cassese S, Park DW, Burzotta F, Byrne RA, Tada T, King LA, Park SJ, Schomig A, Kastrati A (2012) Everolimus-eluting versus sirolimus-eluting stents: an updated meta-analysis of randomized trials. Clin Res Cardiol 101(6):461–467. doi:10.1007/s00392-012-0414-8
Akin I, Hochadel M, Abdel-Wahab M, Senges J, Richardt G, Schneider S, Tebbe U, Kuck KH, Nienaber CA (2013) Clinical outcomes of different first- and second-generation drug-eluting stents in routine clinical practice: results from the prospective multicenter German DES.DE registry. Clin Res Cardiol 102(5):371–381. doi:10.1007/s00392-013-0546-5
Akin I, Naber C, Sabin G, Hochadel M, Senges J, Kuck KH, Nienaber C, Richardt G, Tolg R (2013) Outcome of percutaneous coronary intervention with drug-eluting stents in unprotected left main versus non-left main native coronary artery disease: results from the prospective multicenter German DES.DE registry. Clin Res Cardiol 102(9):679–686. doi:10.1007/s00392-013-0582-1
Adams DH, Popma JJ, Reardon MJ, Yakubov SJ, Coselli JS, Deeb GM, Gleason TG, Buchbinder M, Hermiller J Jr, Kleiman NS, Chetcuti S, Heiser J, Merhi W, Zorn G, Tadros P, Robinson N, Petrossian G, Hughes GC, Harrison JK, Conte J, Maini B, Mumtaz M, Chenoweth S, Oh JK, Investigators USCC (2014) Transcatheter aortic-valve replacement with a self-expanding prosthesis. N Engl J Med 370(19):1790–1798. doi:10.1056/NEJMoa1400590
Mohr FW, Holzhey D, Mollmann H, Beckmann A, Veit C, Figulla HR, Cremer J, Kuck KH, Lange R, Zahn R, Sack S, Schuler G, Walther T, Beyersdorf F, Bohm M, Heusch G, Funkat AK, Meinertz T, Neumann T, Papoutsis K, Schneider S, Welz A, Hamm CW, Board GE (2014) The German Aortic Valve Registry: 1-year results from 13,680 patients with aortic valve disease. Eur J Cardiothorac Surg 46(5):808–816. doi:10.1093/ejcts/ezu290
Williams M, Kodali SK, Hahn RT, Humphries KH, Nkomo VT, Cohen DJ, Douglas PS, Mack M, McAndrew TC, Svensson L, Thourani VH, Tuzcu EM, Weissman NJ, Kirtane AJ, Leon MB (2014) Sex-related differences in outcomes after transcatheter or surgical aortic valve replacement in patients with severe aortic stenosis: insights from the PARTNER Trial (Placement of Aortic Transcatheter Valve). J Am Coll Cardiol 63(15):1522–1528. doi:10.1016/j.jacc.2014.01.036
Lindman BR, Pibarot P, Arnold SV, Suri RM, McAndrew TC, Maniar HS, Zajarias A, Kodali S, Kirtane AJ, Thourani VH, Tuzcu EM, Svensson LG, Waksman R, Smith CR, Leon MB (2014) Transcatheter versus surgical aortic valve replacement in patients with diabetes and severe aortic stenosis at high risk for surgery: an analysis of the PARTNER Trial (Placement of Aortic Transcatheter Valve). J Am Coll Cardiol 63(11):1090–1099. doi:10.1016/j.jacc.2013.10.057
Dvir D, Waksman R, Barbash IM, Kodali SK, Svensson LG, Tuzcu EM, Xu K, Minha S, Alu MC, Szeto WY, Thourani VH, Makkar R, Kapadia S, Satler LF, Webb JG, Leon MB, Pichard AD (2014) Outcomes of patients with chronic lung disease and severe aortic stenosis treated with transcatheter versus surgical aortic valve replacement or standard therapy: insights from the PARTNER trial (placement of AoRTic TraNscathetER Valve). J Am Coll Cardiol 63(3):269–279. doi:10.1016/j.jacc.2013.09.024
Onorati F, D’Errigo P, Grossi C, Barbanti M, Ranucci M, Covello DR, Rosato S, Maraschini A, Santoro G, Tamburino C, Seccareccia F, Santini F, Menicanti L, Group OR (2014) Effect of severe left ventricular systolic dysfunction on hospital outcome after transcatheter aortic valve implantation or surgical aortic valve replacement: results from a propensity-matched population of the Italian OBSERVANT multicenter study. J Thorac Cardiovasc Surg 147(2):568–575. doi:10.1016/j.jtcvs.2013.10.006
Illmann A, Riemer T, Erbel R, Giannitsis E, Hamm C, Haude M, Heusch G, Maier LS, Munzel T, Schmitt C, Schumacher B, Senges J, Voigtlander T, Mudra H (2014) Disease distribution and outcome in troponin-positive patients with or without revascularization in a chest pain unit: results of the German CPU-Registry. Clin Res Cardiol 103(1):29–40. doi:10.1007/s00392-013-0619-5
Meinertz T, Diegeler A, Stiller B, Fleck E, Heinemann MK, Schmaltz AA, Vestweber M, Bestehorn K, Beckmann A, Hamm C, Cremer J (2015) German Heart Report 2013. Clin Res Cardiol 104(2):112–123. doi:10.1007/s00392-014-0799-7
Zeymer U, Arntz HR, Mark B, Fichtlscherer S, Werner G, Scholler R, Zahn R, Diller F, Darius H, Dill T, Huber K (2012) Efficacy and safety of a high loading dose of clopidogrel administered prehospitally to improve primary percutaneous coronary intervention in acute myocardial infarction: the randomized CIPAMI trial. Clin Res Cardiol 101(4):305–312. doi:10.1007/s00392-011-0393-1
Chu VH, Park LP, Athan E, Delahaye F, Freiberger T, Lamas C, Miro JM, Mudrick DW, Strahilevitz J, Tribouilloy C, Durante-Mangoni E, Pericas JM, Fernandez-Hidalgo N, Nacinovich F, Rizk H, Krajinovic V, Giannitsioti E, Hurley JP, Hannan MM, Wang A (2014) The association between surgical indications, operative risk and clinical outcome in infective endocarditis: a prospective study from the international collaboration on endocarditis. Circulation. doi:10.1161/CIRCULATIONAHA.114.012461
Kulik A, Masters RG, Bedard P, Hendry PJ, Lam BK, Rubens FD, Mesana TG, Ruel M (2010) Postoperative lipid-lowering therapy and bioprosthesis structural valve deterioration: justification for a randomised trial? Eur J Cardiothorac Surg 37(1):139–144. doi:10.1016/j.ejcts.2009.06.051
Pullan M, Chalmers J, Mediratta N, Shaw M, McShane J, Poullis M (2014) Statins and long-term survival after isolated valve surgery: the importance of valve type, position and procedure. Eur J Cardiothorac Surg 45(3):419–424. doi:10.1093/ejcts/ezt399 (discussion 424–415)
Flameng W, Rega F, Vercalsteren M, Herijgers P, Meuris B (2014) Antimineralization treatment and patient-prosthesis mismatch are major determinants of the onset and incidence of structural valve degeneration in bioprosthetic heart valves. J Thorac Cardiovasc Surg 147(4):1219–1224. doi:10.1016/j.jtcvs.2013.03.025
Pibarot P, Weissman NJ, Stewart WJ, Hahn RT, Lindman BR, McAndrew T, Kodali SK, Mack MJ, Thourani VH, Miller DC, Svensson LG, Herrmann HC, Smith CR, Rodes-Cabau J, Webb J, Lim S, Xu K, Hueter I, Douglas PS, Leon MB (2014) Incidence and sequelae of prosthesis-patient mismatch in transcatheter versus surgical valve replacement in high-risk patients with severe aortic stenosis: a PARTNER trial cohort–a analysis. J Am Coll Cardiol 64(13):1323–1334. doi:10.1016/j.jacc.2014.06.1195
Zannis K, Folliguet T, Laborde F (2012) New sutureless aortic valve prosthesis: another tool in less invasive aortic valve replacement. Curr Opin Cardiol 27(2):125–129. doi:10.1097/HCO.0b013e3283501a11
Dalen M, Biancari F, Rubino AS, Santarpino G, De Praetere H, Kasama K, Juvonen T, Deste W, Pollari F, Meuris B, Fischlein T, Mignosa C, Gatti G, Pappalardo A, Sartipy U, Svenarud P (2014) Ministernotomy versus full sternotomy aortic valve replacement with a sutureless bioprosthesis: a multicenter study. Ann Thorac Surg. doi:10.1016/j.athoracsur.2014.08.028
Miceli A, Murzi M, Gilmanov D, Fuga R, Ferrarini M, Solinas M, Glauber M (2014) Minimally invasive aortic valve replacement using right minithoracotomy is associated with better outcomes than ministernotomy. J Thorac Cardiovasc Surg 148(1):133–137. doi:10.1016/j.jtcvs.2013.07.060
Dal-Bianco JP, Beaudoin J, Handschumacher MD, Levine RA (2014) Basic mechanisms of mitral regurgitation. Can J Cardiol 30(9):971–981. doi:10.1016/j.cjca.2014.06.022
Smith PK, Puskas JD, Ascheim DD, Voisine P, Gelijns AC, Moskowitz AJ, Hung JW, Parides MK, Ailawadi G, Perrault LP, Acker MA, Argenziano M, Thourani V, Gammie JS, Miller MA, Page P, Overbey JR, Bagiella E, Dagenais F, Blackstone EH, Kron IL, Goldstein DJ, Rose EA, Moquete EG, Jeffries N, Gardner TJ, O’Gara PT, Alexander JH, Michler RE, Cardiothoracic Surgical Trials Network I (2014) Surgical treatment of moderate ischemic mitral regurgitation. N Engl J Med 371(23):2178–2188. doi:10.1056/NEJMoa1410490
Yin L, Wang Z, Shen H, Min J, Ling X, Xi W (2014) Coronary artery bypass grafting versus combined coronary artery bypass grafting and mitral valve repair in treating ischaemic mitral regurgitation: a meta-analysis. Heart Lung Circ 23(10):905–912. doi:10.1016/j.hlc.2014.03.031
Acker MA, Parides MK, Perrault LP, Moskowitz AJ, Gelijns AC, Voisine P, Smith PK, Hung JW, Blackstone EH, Puskas JD, Argenziano M, Gammie JS, Mack M, Ascheim DD, Bagiella E, Moquete EG, Ferguson TB, Horvath KA, Geller NL, Miller MA, Woo YJ, D’Alessandro DA, Ailawadi G, Dagenais F, Gardner TJ, O’Gara PT, Michler RE, Kron Ctsn IL (2014) Mitral-valve repair versus replacement for severe ischemic mitral regurgitation. N Engl J Med 370(1):23–32. doi:10.1056/NEJMoa1312808
MacHaalany J, Senechal M, O’Connor K, Abdelaal E, Plourde G, Voisine P, Rimac G, Tardif MA, Costerousse O, Bertrand OF (2014) Early and late mortality after repair or replacement in mitral valve prolapse and functional ischemic mitral regurgitation: a systematic review and meta-analysis of observational studies. Int J Cardiol 173(3):499–505. doi:10.1016/j.ijcard.2014.02.029
Wagner CE, Kron IL (2014) Subvalvular techniques to optimize surgical repair of ischemic mitral regurgitation. Curr Opin Cardiol 29(2):140–144. doi:10.1097/HCO.0000000000000042
Boekstegers P, Hausleiter J, Baldus S, von Bardeleben RS, Beucher H, Butter C, Franzen O, Hoffmann R, Ince H, Kuck KH, Rudolph V, Schafer U, Schillinger W, Wunderlich N, Germany Society of Cardiology Working Group on Interventional Cardiology Focus Group on Interventional Mitral Valve T (2014) Percutaneous interventional mitral regurgitation treatment using the Mitra-Clip system. Clin Res Cardiol 103(2):85–96. doi:10.1007/s00392-013-0614-x
Ledwoch J, Franke J, Baldus S, Schillinger W, Bekeredjian R, Boekstegers P, Hink U, Kuck KH, Ouarrak T, Mollmann H, Nickenig G, Senges J, Franzen O, Sievert H (2014) Impact of the learning curve on outcome after transcatheter mitral valve repair: results from the German Mitral Valve Registry. Clin Res Cardiol 103(11):930–937. doi:10.1007/s00392-014-0734-y
Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP 3rd, Guyton RA, O’Gara PT, Ruiz CE, Skubas NJ, Sorajja P, Sundt TM 3rd, Thomas JD, American College of Cardiology/American Heart Association Task Force on Practice G (2014) 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 63(22):e57–185. doi:10.1016/j.jacc.2014.02.536
Glower DD, Kar S, Trento A, Lim DS, Bajwa T, Quesada R, Whitlow PL, Rinaldi MJ, Grayburn P, Mack MJ, Mauri L, McCarthy PM, Feldman T (2014) Percutaneous mitral valve repair for mitral regurgitation in high-risk patients: results of the EVEREST II study. J Am Coll Cardiol 64(2):172–181. doi:10.1016/j.jacc.2013.12.062
Lim DS, Reynolds MR, Feldman T, Kar S, Herrmann HC, Wang A, Whitlow PL, Gray WA, Grayburn P, Mack MJ, Glower DD (2014) Improved functional status and quality of life in prohibitive surgical risk patients with degenerative mitral regurgitation after transcatheter mitral valve repair. J Am Coll Cardiol 64(2):182–192. doi:10.1016/j.jacc.2013.10.021
Mihaljevic T, Koprivanac M, Kelava M, Goodman A, Jarrett C, Williams SJ, Gillinov AM, Bajwa G, Mick SL, Bonatti J, Blackstone EH (2014) Value of robotically assisted surgery for mitral valve disease. JAMA Surg 149(7):679–686. doi:10.1001/jamasurg.2013.5680
Nasso G, Bonifazi R, Romano V, Bartolomucci F, Rosano G, Massari F, Fattouch K, Del Prete G, Riccioni G, Del Giglio M, Speziale G (2014) Three-year results of repaired Barlow mitral valves via right minithoracotomy versus median sternotomy in a randomized trial. Cardiology 128(2):97–105. doi:10.1159/000357263
Nath J, Foster E, Heidenreich PA (2004) Impact of tricuspid regurgitation on long-term survival. J Am Coll Cardiol 43(3):405–409. doi:10.1016/j.jacc.2003.09.036
Kim JB, Spevack DM, Tunick PA, Bullinga JR, Kronzon I, Chinitz LA, Reynolds HR (2008) The effect of transvenous pacemaker and implantable cardioverter defibrillator lead placement on tricuspid valve function: an observational study. J Am Soc Echocardiogr 21(3):284–287. doi:10.1016/j.echo.2007.05.022
Ratschiller T, Guenther T, Knappich C, Guenzinger R, Kehl V, Voss B, Lange R (2014) Do transvalvular pacemaker leads influence functional outcome after tricuspid ring annuloplasty? Eur J Cardiothorac Surg. doi:10.1093/ejcts/ezu449
Goldstone AB, Howard JL, Cohen JE, MacArthur JW Jr, Atluri P, Kirkpatrick JN, Woo YJ (2014) Natural history of coexistent tricuspid regurgitation in patients with degenerative mitral valve disease: implications for future guidelines. J Thorac Cardiovasc Surg 148(6):2802–2810. doi:10.1016/j.jtcvs.2014.08.001
Rajbanshi BG, Suri RM, Nkomo VT, Dearani JA, Daly RC, Burkhart HM, Stulak JM, Joyce LD, Li Z, Schaff HV (2014) Influence of mitral valve repair versus replacement on the development of late functional tricuspid regurgitation. J Thorac Cardiovasc Surg 148(5):1957–1962. doi:10.1016/j.jtcvs.2014.04.041
Joint Task Force on the Management of Valvular Heart Disease of the European Society of C, European Association for Cardio-Thoracic S, Vahanian A, Alfieri O, Andreotti F, Antunes MJ, Baron-Esquivias G, Baumgartner H, Borger MA, Carrel TP, De Bonis M, Evangelista A, Falk V, Iung B, Lancellotti P, Pierard L, Price S, Schafers HJ, Schuler G, Stepinska J, Swedberg K, Takkenberg J, Von Oppell UO, Windecker S, Zamorano JL, Zembala M (2012) Guidelines on the management of valvular heart disease (version 2012). Eur Heart J 33(19):2451–2496. doi:10.1093/eurheartj/ehs109
Addetia K, Maffessanti F, Mediratta A, Yamat M, Weinert L, Moss JD, Nayak HM, Burke MC, Patel AR, Kruse E, Jeevanandam V, Mor-Avi V, Lang RM (2014) Impact of implantable transvenous device lead location on severity of tricuspid regurgitation. J Am Soc Echocardiogr 27(11):1164–1175. doi:10.1016/j.echo.2014.07.004
Starling RC, Moazami N, Silvestry SC, Ewald G, Rogers JG, Milano CA, Rame JE, Acker MA, Blackstone EH, Ehrlinger J, Thuita L, Mountis MM, Soltesz EG, Lytle BW, Smedira NG (2014) Unexpected abrupt increase in left ventricular assist device thrombosis. N Engl J Med 370(1):33–40. doi:10.1056/NEJMoa1313385
Boyle AJ, Jorde UP, Sun B, Park SJ, Milano CA, Frazier OH, Sundareswaran KS, Farrar DJ, Russell SD, HeartMate IICI (2014) Pre-operative risk factors of bleeding and stroke during left ventricular assist device support: an analysis of more than 900 HeartMate II outpatients. J Am Coll Cardiol 63(9):880–888. doi:10.1016/j.jacc.2013.08.1656
Milano C, Pagani FD, Slaughter MS, Pham DT, Hathaway DR, Jacoski MV, Najarian KB, Aaronson KD, Investigators A (2014) Clinical outcomes after implantation of a centrifugal flow left ventricular assist device and concurrent cardiac valve procedures. Circulation 130(11 Suppl 1):S3–11. doi:10.1161/CIRCULATIONAHA.113.007911
Fujita T, Kobayashi J, Hata H, Seguchi O, Murata Y, Yanase M, Nakatani T (2014) Right heart failure and benefits of adjuvant tricuspid valve repair in patients undergoing left ventricular assist device implantation. Eur J Cardiothorac Surg 46(5):802–807. doi:10.1093/ejcts/ezu040
Brewer RJ, Cabrera R, El-Atrache M, Zafar A, Hrobowski TN, Nemeh HM, Selektor Y, Paone G, Williams CT, Velez M, Tita C, Morgan JA, Lanfear DE (2014) Relationship of tricuspid repair at the time of left ventricular assist device implantation and survival. Int J Artificial Organs 37(11):834–838. doi:10.5301/ijao.5000369
Topkara VK, O’Neill JK, Carlisle A, Novak E, Silvestry SC, Ewald GA (2014) HeartWare and HeartMate II left ventricular assist devices as bridge to transplantation: a comparative analysis. Ann Thorac Surg 97(2):506–512. doi:10.1016/j.athoracsur.2013.08.048
Lalonde SD, Alba AC, Rigobon A, Ross HJ, Delgado DH, Billia F, McDonald M, Cusimano RJ, Yau TM, Rao V (2013) Clinical differences between continuous flow ventricular assist devices: a comparison between HeartMate II and HeartWare HVAD. J Card Surg 28(5):604–610. doi:10.1111/jocs.12158
Pulikottil-Jacob R, Suri G, Connock M, Kandala NB, Sutcliffe P, Maheswaran H, Banner NR, Clarke A (2014) Comparative cost-effectiveness of the HeartWare versus HeartMate II left ventricular assist devices used in the United Kingdom National Health Service bridge-to-transplant program for patients with heart failure. J Heart Lung Transplant 33(4):350–358. doi:10.1016/j.healun.2014.01.003
Singh TP, Milliren CE, Almond CS, Graham D (2014) Survival benefit from transplantation in patients listed for heart transplantation in the United States. J Am Coll Cardiol 63(12):1169–1178. doi:10.1016/j.jacc.2013.11.045
Kansara P, Czer L, Awad M, Arabia F, Mirocha J, De Robertis M, Moriguchi J, Ramzy D, Kass RM, Esmailian F, Trento A, Kobashigawa J (2014) Heart transplantation with and without prior sternotomy: analysis of the United Network for Organ Sharing database. Transplant Proc 46(1):249–255. doi:10.1016/j.transproceed.2013.09.027
Erbel R, Aboyans V, Boileau C, Bossone E, Bartolomeo RD, Eggebrecht H, Evangelista A, Falk V, Frank H, Gaemperli O, Grabenwoger M, Haverich A, Iung B, Manolis AJ, Meijboom F, Nienaber CA, Roffi M, Rousseau H, Sechtem U, Sirnes PA, Allmen RS, Vrints CJ, Guidelines ESCCfP (2014) 2014 ESC Guidelines on the diagnosis and treatment of aortic diseases: Document covering acute and chronic aortic diseases of the thoracic and abdominal aorta of the adult. The Task Force for the Diagnosis and Treatment of Aortic Diseases of the European Society of Cardiology (ESC). Eur Heart J 35(41):2873–2926. doi:10.1093/eurheartj/ehu281
De Paulis R, Czerny M, Weltert L, Bavaria J, Borger MA, Carrel TP, Etz CD, Grimm M, Loubani M, Pacini D, Resch T, Urbanski PP, Weigang E (2014) Current trends in cannulation and neuroprotection during surgery of the aortic arch in Europedaggerdouble dagger. Eur J Cardiothorac Surg. doi:10.1093/ejcts/ezu284
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
On behalf of all authors, the corresponding author states that there is no conflict of interest.
Rights and permissions
About this article
Cite this article
Doenst, T., Strüning, C., Moschovas, A. et al. Cardiac surgery 2014 reviewed. Clin Res Cardiol 104, 1006–1020 (2015). https://doi.org/10.1007/s00392-015-0914-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00392-015-0914-4